NCRI 2016 | Future directions for APOBEC studies

Reuben Harris

Reuben Harris, PhD of University of Minnesota, Minneapolis, MN discusses future directions for APOBEC studies. Dr Harris’ laboratory is interested in understanding the APOBEC mechanism in order to reveal some clinical vulnerabilities. In addition, Dr Harris collaborates with others to target evolvability and shut off APOBEC-3B or APOBEC-3H to ultimately slow down tumor mutation rate and improve clinical outcomes. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter